...
首页> 外文期刊>Bulletin of Clinical Psychopharmacology >Topiramate in the adjunct?ve treatment of tourette syndrome: a case report
【24h】

Topiramate in the adjunct?ve treatment of tourette syndrome: a case report

机译:托吡酯在抽动秽语综合征的辅助治疗中:一例报告

获取原文
           

摘要

Tourette Syndrome (TS) is an inherited neuropsychiatric disorder with onset in childhood, characterized by multiple motor tics and at least one vocal tic. In many of the cases, Attention Deficit Hyperactivity Disorder (ADHD) is a frequent comorbid disorder. Many treatment options have been suggested for TS and ADHD comorbidity. In this article, we present a case diagnosed with TS and ADHD whose tics were refractory to many other suggested treatment options for Tic Disorders (TD) and worsened during the use of recommended first-line treatment agents for ADHD, that were significantly reduced by using topiramate. New therapeutic options that would be easily used and with less side effects are needed in the treatment of TD. Topiramate treatment seems like an appropriate option raising hope for the future to be used as monotherapy or in adjuvant treatment for TD. Larger trials with longer follow up are required in this field.
机译:Tourette综合征(TS)是一种遗传性神经精神病,发病于儿童期,特征是多发运动性抽动和至少一个声带抽动。在许多情况下,注意力缺陷多动障碍(ADHD)是一种常见的合并症。对于TS和ADHD合并症,已经提出了许多治疗选择。在本文中,我们介绍了一个被确诊为TS和ADHD的病例,其抽动对其他许多建议的Tic障碍(TD)治疗选择均无效,并且在使用推荐的ADHD一线治疗药物期间恶化了,托吡酯。在TD的治疗中需要易于使用且副作用较少的新的治疗选择。托吡酯治疗似乎是一种适当的选择,这为将来将其用作TD的单药治疗或辅助治疗带来了希望。在该领域中,需要进行较大规模的试验并需要更长的随访时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号